fasudil has been researched along with Encephalomyelitis, Inflammatory in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Excerpt | Relevance | Reference |
---|---|---|
" Although Fasudil, a ROCK inhibitor, effectively suppressed encephalomyelitis (EAE), certain side effects may limit its clinical use." | 3.81 | FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity. ( Chai, Z; Feng, L; Jiang, WJ; Li, YH; Liu, CY; Ma, CG; Wang, Q; Xiao, BG; Xin, YL; Yang, WF; Yang, XW; Yu, JZ; Zhang, GX, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xin, YL | 1 |
Yu, JZ | 1 |
Yang, XW | 1 |
Liu, CY | 1 |
Li, YH | 1 |
Feng, L | 1 |
Chai, Z | 1 |
Yang, WF | 1 |
Wang, Q | 1 |
Jiang, WJ | 1 |
Zhang, GX | 1 |
Xiao, BG | 1 |
Ma, CG | 1 |
1 other study available for fasudil and Encephalomyelitis, Inflammatory
Article | Year |
---|---|
FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Autoimmunity; Cell Survival; Cells, Cultured | 2015 |